Loading...
Preclinical Efficacy and Safety of a Human Embryonic Stem Cell-Derived Midbrain Dopamine Progenitor Product, MSK-DA01
Parkinson’s disease is characterized by the loss of dopaminergic neurons in the substantia nigra leading to disabling deficits. Dopamine neuron grafts may provide a significant therapeutic advance over current therapies. We have generated midbrain dopamine neurons from human embryonic stem cells and...
Na minha lista:
| Udgivet i: | Cell Stem Cell |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7903922/ https://ncbi.nlm.nih.gov/pubmed/33545080 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.stem.2021.01.004 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|